Why did Trump’s megabill face a tight Senate vote?
How is Tesla’s stock impacted by Musk-Trump feud?
What’s driving Amazon’s deployment of one million robots?
Why are U.S. tariffs delaying Federal Reserve rate cuts?
How will Trump’s bill affect clean energy tax credits?
Why is Qantas facing a major data breach?
What caused Greggs’ sales to plunge amid heatwave?
Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Strong Tailwind
investors.com/research/biotech-stock-heart-drug-kiniksa-knsa/?src=A00220
Kiniksa Pharmaceuticals (KNSA) shares currently hover just below a buy point, making the biotech stock Tuesday's choice for IBD 50 Stocks To Watch. The Lexington, Mass.-based drugmaker focuses on treatments for rare diseases. Its primary drug Arcalyst treats recurring pericarditis, a…
This story appeared on investors.com, 2025-07-01 17:37:15.